Novartis AG (NVS) offers a reliable 2.34% dividend yield with a low payout ratio, steady earnings growth, and global healthcare leadership. Despite sales stagnation, Novartis presents an undervalued opportunity for long-term investors seeking income and growth.
Read MoreDid you find this insightful?
Bad
Just Okay
Amazing